Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Masimo Corp (MASI)

Masimo Corp (MASI)
80.00 x 10 190.00 x 1
Post-market by (Cboe BZX)
153.61 -0.29 (-0.19%) 04/14/25 [NASDAQ]
80.00 x 10 190.00 x 1
Post-market 153.61 unch (unch) 16:34 ET
News & Headlines for Mon, Apr 14th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

RMD : 214.53 (+0.25%)
MASI : 153.61 (-0.19%)
PODD : 255.47 (+0.58%)
IRTC : 103.20 (+1.09%)
DXCM : 67.39 (+1.89%)
Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

RMD : 214.53 (+0.25%)
MASI : 153.61 (-0.19%)
IRTC : 103.20 (+1.09%)
PODD : 255.47 (+0.58%)
DXCM : 67.39 (+1.89%)
Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers

Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers

RMD : 214.53 (+0.25%)
MASI : 153.61 (-0.19%)
PODD : 255.47 (+0.58%)
IRTC : 103.20 (+1.09%)
DXCM : 67.39 (+1.89%)
Masimo (MASI): Buy, Sell, or Hold Post Q4 Earnings?

Masimo (MASI): Buy, Sell, or Hold Post Q4 Earnings?

YUM : 146.00 (+0.69%)
MASI : 153.61 (-0.19%)
3 Small-Cap Stocks in Hot Water

3 Small-Cap Stocks in Hot Water

MASI : 153.61 (-0.19%)
PLCE : 5.74 (-15.27%)
NMRK : 10.71 (+3.88%)
Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)

Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)

RMD : 214.53 (+0.25%)
MASI : 153.61 (-0.19%)
IRTC : 103.20 (+1.09%)
PODD : 255.47 (+0.58%)
DXCM : 67.39 (+1.89%)
FMS Stock Gains Following Stake Sale to Reduce Debt & Boost Profit

Fresenius Medical Care’s FMS parent company Fresenius SE raised nearly €1.1 billion ($1.2 billion) through a strategic sale of shares in Fresenius Medical Care AG and the issuance of exchangeable bonds...

BSX : 94.27 (+0.64%)
MASI : 153.61 (-0.19%)
CAH : 134.78 (+2.28%)
FMS : 24.67 (+2.88%)
Baxter Stock Likely to Gain Following the Introduction of Voalte Linq

Baxter International Inc. BAX recently introduced Voalte Linq , a lightweight, wearable badge powered by Scotty assistant, a voice-activated technology, at the 2025 HIMSS Global Healthcare Conference....

BSX : 94.27 (+0.64%)
BAX : 28.38 (+1.94%)
MASI : 153.61 (-0.19%)
CAH : 134.78 (+2.28%)
Should Labcorp Stock Stay in Your Portfolio Right Now?

Labcorp Holdings Inc. LH, or Labcorp, is prioritizing key specialty testing areas, such as oncology, women’s health, autoimmune disease and neurology, aiming to tap into strong growth opportunities....

BSX : 94.27 (+0.64%)
MASI : 153.61 (-0.19%)
CAH : 134.78 (+2.28%)
LH : 228.04 (+2.97%)
Nevro Q4 Earnings & Revenues Beat Estimates, Gross Margin Down

Nevro Corp. NVRO reported a loss per share of 64 cents in the fourth quarter of 2024, wider than the year-ago quarter’s loss of 15 cents. The Zacks Consensus Estimate is pegged at a loss per share of...

NVRO : 5.84 (unch)
AVAH : 4.71 (+4.90%)
MASI : 153.61 (-0.19%)
ATEC : 10.18 (+4.41%)

Barchart Exclusives

Should You Buy Apple Stock on the ‘Liberation Day’ Dip?
Down almost 25% from all-time highs, Apple stock is unlikely to deliver outsized gains to long-term shareholders despite the ongoing pullback in valuation. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar